Contract 36F79719D0194
Paratek Pharmaceuticals, Inc · Department Of Veterans Affairs · July 2, 2019
Paratek Pharmaceuticals, Inc was awarded a federal contract by Department Of Veterans Affairs on July 2, 2019 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 33 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 29, 2026. If all options are exercised, the contract could reach $225,000.
Contract details
- PIID
- 36F79719D0194
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- July 2, 2019
- Latest action
- January 29, 2026
Description
CONTRACT EXTENSION
Modification timeline
-
January 29, 2026Mod P00033$0
-
December 4, 2025Mod P00032PUBLIC LAW 2026$0
-
August 25, 2025Mod P00031EPA$0
-
March 24, 2025Mod P00029$0
-
March 20, 2025Mod P00030ADMINISTRATION CHANGE (POC)$0
-
February 13, 2025Mod P00028EPA$0
-
December 16, 2024Mod P00027PUBLIC LAW 2025$0
-
August 28, 2024Mod P00026EPA$0
-
June 7, 2024Mod P00025$0
-
March 5, 2024Mod P00024EPA$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79719D0194?
Contract 36F79719D0194 is a federal contract awarded to Paratek Pharmaceuticals, Inc by Department Of Veterans Affairs on July 2, 2019 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 33 times since the base award.
Who won contract 36F79719D0194?
Paratek Pharmaceuticals, Inc won contract 36F79719D0194 from Department Of Veterans Affairs.
How much is contract 36F79719D0194 worth?
Contract 36F79719D0194 has obligated $0 to date but carries a potential ceiling of $225,000 if fully funded and all options are exercised.